|Appearance||White crystalline powder|
Tadalafil is a second generation phosphodiesterase 5 inhibitors, an oral treatment of male erectile dysfunction drug, studies show, compared with sildenafil, Cialis onset is very rapid, about 15 ~ 20 min onset, the effect of long-term, up to 36h. T1/2 is 17.5h. In a 348 patients with mild to severe erectile dysfunction, male participation in the study, patients were randomized to tadalafil 20mg or placebo, results showed that compared with placebo, successful intercourse at 24 and 36 hours after dosing resistance are improved, the majority of male secondary sexual intercourse can occur successfully at 36 hours, and the incidence of adverse drug reactions and severity also no difference compared with placebo.
Other Name：cyclopentyl (2S)-2-[[(2R)-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl]amino]-2-phenylacetate; CHR2797-Tosedostat; CHR-2797; UNII-KZK563J2UW.
Tadalafil is a PDE5 inhibitor（The inhibition of phosphodiesterase type 5 (PDE5) enhances erectile function by increasing the amount of cGMP）.
Tadalafil is used to treat erectile dysfunction (impotence) and symptoms of benign prostatic hypertrophy (enlarged prostate). Tadalafil is used to treat pulmonary arterial hypertension and improve exercise capacity in men and women.Tadalafil is an oral drug for the treatment of ED, used in the treatment of erectile dysfunction and premature ejaculation, erectile function impairment and premature ejaculation has very significant improvements. help both husband and wife a satisfactory sex life.
tadalafil relaxes muscles of the blood vessels and increases blood flow to particular areas of the body.
Tadalafil has been approximately 15,000 men participating in clinical trials and more than 8 million men worldwide (primarily in the post-approval / listing of the environment) and the use as a means of treatment of ED.
On November 21, 2003, the FDA approved tadalafil (as Cialis) for sale in the United States as the third ED prescription drug pill (after sildenafil citrate ( Viagra ) and vardenafil (Levitra)).
Tadalafil was approved in May 2009 in the United States for the treatment of pulmonary arterial hypertension and is under regulatory review in other regions for this condition
On October 6, 2011, the US FDA approved tadalafil to treat the signs and symptoms of benign prostatic hyperplasia (BPH).
Send inquiry online For more product information and prices
(Pharmaceutical Ingredients Manufacturer & Supplier & Exporter.)
After sending the online inquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email. —— Green Stone SwissEmail: [email protected]
Tel: +86 592 5365887
WhatsApp: +86 189 6515 7632
Send inquiry online: